Symbol
|
MZPLTQ | P319TQ | P308TQ | NGFLTQ | P322TQ | VDALTQ | VBMLTQ | VXULTQ | WEVLTQ | RMASRV | RMAJLV | WXNLTQ | EOJRCH | RMABXV | ICOEFG | NELRCH | YOTLTQ | NPYRCH | RMBWDV | RMAVSV |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Name | Multi Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible | Worst of Reverse Convertible | Worst of Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible | Multi Vonti | Multi Vonti | Multi Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | Reverse Convertible | Worst of Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | Multi Vonti |
Underlying
|
Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / Zurich Insurance Group AG | Compagnie Financière Richemont SA / Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG | Lonza Group N / Novartis Sandoz Basket / Roche AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / UBS Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG | Compagnie Financière Richemont SA / Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Zurich Insurance Group AG | Nestlé / Novartis / Roche GS | Nestlé / Novartis / Roche GS / Zurich | Novartis / Roche GS / Swiss Life / Zurich | Nestlé / Novartis / Roche GS | Novartis AG / Sika AG / Swisscom N / Zurich Insurance Group AG | Nestlé / Novartis / Roche GS / UBS / Zurich | Holcim AG / Kühne & Nagel Intl. AG / Nestlé S.A. / Novartis AG / Roche AG |
Issuer
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Date of maturity
|
07.07.2025 | 08.09.2025 | 07.10.2025 | 07.10.2025 | 23.12.2025 | 16.09.2025 | 30.09.2025 | 11.07.2025 | 31.03.2028 | 10.02.2026 | 10.06.2025 | 30.06.2028 | 14.01.2026 | 12.10.2026 | 03.11.2028 | 03.11.2025 | 24.11.2027 | 02.02.2026 | 27.07.2026 | 23.02.2026 |
Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Strike price
|
66.70 | 63.19 | 63.93 | 63.93 | 64.42 | 55.81 | 53.41 | 203.76 | 49.63 | 51.70 | 86.32 | 70.71 | 188.09 | 65.70 | - | 67.008 | 63.075 | 360.18 | 16.24 | 47.42 |
Max. yield p.a. | 101.10% | 56.52% | 47.86% | 46.35% | 28.53% | 0.27% | -0.06% | 8.25% | 4.65% | 6.52% | 24.51% | 6.21% | 5.34% | 6.46% | - | 2.67% | 4.89% | 6.45% | 7.54% | 16.69% |
Bid | 99.35 | 97.07 | 96.42 | 96.96 | 98.86 | 101.14 | 100.74 | 99.30 | 100.59 | 100.80 | 98.00 | 95.59 | 99.76 | - | 105.19 | 101.29 | 100.16 | 98.91 | 98.00 | 90.90 |
Ask | 100.15 | 97.87 | 97.22 | 97.76 | 99.66 | 101.95 | 101.55 | 100.10 | 101.40 | 102.30 | 101.30 | 96.39 | 100.56 | - | - | 102.10 | 100.96 | 99.71 | 99.50 | 92.30 |